CD4+T CELLS, IMMUNOGLOBULINS AND RISK OF INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS OVER MULTIPLE CYCLES OF RITUXIMAB

被引：0
|
作者：
Martins, F. [1 ]
Bensalem, A. [2 ]
Bejan-Angoulvant, T. [2 ,3 ]
Lhommas, A. [1 ]
Melet, J. [1 ,2 ]
Mammou, S. [1 ]
Thibault, G. [2 ,4 ,5 ]
Bernard, L. [6 ]
Goupille, P. [1 ,2 ]
Mulleman, D. [1 ,2 ]
机构：
[1] CHRU Tours, Rheumatol, Tours, France
[2] Univ Tours, EA GICC, Tours, France
[3] CHRU Tours, Clin Pharmacol, Tours, France
[4] Univ Tours, CNRS ERL 7001, Tours, France
[5] CHRU Tours, Immunol, Tours, France
[6] CHRU Tours, Infect Dis, Tours, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.7030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0194
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [1] Repeated CD4+T-Cell Depletion in Patients with Rheumatoid Arthritis over Multiple Cycles of Rituximab Treatment
    Lavielle, Matthieu
    Mulleman, Denis
    Sung, Hsueh Cheng
    Bahuaud, Clement
    Goupille, Philippe
    Watier, Herve
    Thibault, Gilles
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] Repeated decrease of CD4+T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
    Lavielle, Matthieu
    Mulleman, Denis
    Goupille, Philippe
    Bahuaud, Clement
    Sung, Hsueh Cheng
    Watier, Herve
    Thibault, Gilles
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [3] CONTRIBUTION OF CD4+T CELLS DECREASE ON CLINICAL RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS
    Bensalem, A.
    Mulleman, D.
    Thibault, G.
    Azzopardi, N.
    Paintaud, G.
    Goupille, P.
    Ternant, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 949 - 949
  • [4] Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
    Matthieu Lavielle
    Denis Mulleman
    Philippe Goupille
    Clément Bahuaud
    Hsueh Cheng Sung
    Hervé Watier
    Gilles Thibault
    Arthritis Research & Therapy, 18
  • [5] INFECTION RISK IN PATIENTS WITH LOW IMMUNOGLOBULINS FOLLOWING RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS
    van Vollenhoven, R.
    Silverman, G. J.
    Bingham, C. O.
    Durez, P.
    Lehane, P. B.
    Tyson, N.
    Fisheleva, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 382 - 382
  • [6] Mass Cytometry Analysis of CD4+T Cells in Patients with Rheumatoid Arthritis
    Su, Laura
    del Alcazar, Daniel
    Marc, Adam
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [7] Infection Risk in Patients with Low Immunoglobulins Following Rituximab Treatment in Rheumatoid Arthritis.
    van Vollenhoven, Ronald F.
    Silverman, Gregg J.
    Bingham, Clifton O., III
    Durez, Patrick
    Lehane, Patrica B.
    Tyson, Nicola
    Fisheleva, Elena
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S724 - S725
  • [8] Citrullinated fibrinogen activates CD4+T cells in patients with rheumatoid arthritis.
    Lacelle, C.
    Zhang, Y.
    Olsen, N.
    Karp, D.
    Stastny, P.
    HUMAN IMMUNOLOGY, 2007, 68 : S124 - S124
  • [9] INSULIN INHIBITS ACTIVITY OF CD4+T CELLS IN RHEUMATOID ARTHRITIS
    Erlandsson, M.
    Tuameh, M.
    Nilsson, L.
    Malmhall-Bah, E.
    Silfversward, S.
    Sandstrom, T. Zverkova
    Andersson, K. M.
    Dehlin, M.
    Pullerits, R.
    Bokarewa, M. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 858 - 858
  • [10] CD4+T CELL RESPONSES TO AUTOANTIGENS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Locke, James
    Diboll, Julie
    von Delwig, Susan Tudhope Alexei
    Isaacs, John D.
    Ng, Wan-Fai
    RHEUMATOLOGY, 2009, 48 : I35 - I36
12345